Endogenous Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Plays a Protective Effect Against Noise-Induced Hearing Loss

Endogenous Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Plays a Protective Effect Against Noise-Induced Hearing Loss

Pituitary adenylyl cyclase-activating polypeptide (PACAP) is a member of the vasoactive intestinal polypeptide (VIP)-the secretin-glucagon family of neuropeptides. They act through two classes of receptors: PACAP type 1 (PAC1) and type 2 (VPAC1 and VPAC2). Among their pleiotropic effects throughout...

Full description

Bibliographic Details
Main Authors:	Jérôme Ruel, Matthieu J. Guitton, Paul Gratias, Marc Lenoir, Sanbing Shen, Jean-Luc Puel, Philippe Brabet, Jing Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Series:	Frontiers in Cellular Neuroscience
Subjects:	acoustic trauma PACAP (pituitary adenylate cyclase-activating polypeptide) PAC1 receptor neuroprotection noise-induced hearing loss (NIHL)
Online Access:	https://www.frontiersin.org/articles/10.3389/fncel.2021.658990/full

Similar Items

Comprehensive behavioral analysis of pituitary adenylate cyclase-activating polypeptide (PACAP) knockout mice
by: Satoko eHattori, et al.
Published: (2012-10-01)

Role of pituitary adenylate cyclase‐activating polypeptide in modulating hypothalamic‐pituitary system
by: Aki Oride, et al.
Published: (2018-07-01)

Pituitary adenylate cyclase-activating polypeptide type 1 receptor signaling evokes long-lasting nociceptive behaviors through the activation of spinal astrocytes in mice
by: Tetsuya Ohnou, et al.
Published: (2016-04-01)

Presence of Systemic Amyloidosis in Mice with Partial Deficiency in Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Aging
by: Jason Sparks, et al.
Published: (2021-08-01)

Pituitary adenylate cyclase-activating polypeptide deficient mice show length abnormalities of the axon initial segment
by: Misaki Iwahashi, et al.
Published: (2023-11-01)

Pituitary Adenylate Cyclase-Activating Polypeptide: A Potent Therapeutic Agent in Oxidative Stress
by: Nadia Sadanandan, et al.
Published: (2021-02-01)

Kynurenic Acid Inhibits the Electrical Stimulation Induced Elevated Pituitary Adenylate Cyclase-Activating Polypeptide Expression in the TNC
by: Tamás Körtési, et al.
Published: (2018-01-01)

Pituitary Adenylate Cyclase-Activating Polypeptide Alleviates Intestinal, Extra-Intestinal and Systemic Inflammatory Responses during Acute <i>Campylobacter jejuni</i>-induced Enterocolitis in Mice
by: Markus M. Heimesaat, et al.
Published: (2020-09-01)

Pituitary Adenylate Cyclase-Activating Polypeptide—A Neuropeptide as Novel Treatment Option for Subacute Ileitis in Mice Harboring a Human Gut Microbiota
by: Stefan Bereswill, et al.
Published: (2019-03-01)

Immunohistochemical Study on the Innervation of the Chicken Pancreas by Pituitary Adenylate Cyclase-Activating Polypeptides (PACAPs)-Containing Nerves
by: Kohzy Hiramatsu, et al.
Published: (2009-07-01)

Integrated Transcriptomic and Proteomic Study of the Mechanism of Action of the Novel Small-Molecule Positive Allosteric Modulator 1 in Targeting PAC1-R for the Treatment of D-Gal-Induced Aging Mice
by: Lili Liang, et al.
Published: (2024-03-01)

Stress-specific changes of galanin and PACAP expression in the rat hypothalamus and adrenal gland
by: Lakić Iva, et al.
Published: (2018-01-01)

Sex-related differences in endogenous pituitary adenylate cyclase-activating polypeptide (PACAP) in the thalamic paraventricular nucleus: Implications for addiction neuroscience
by: Genevieve R. Curtis, et al.
Published: (2023-03-01)

Relationship between Plasma Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Level and Proteome Profile of Cows
by: Levente Czegledi, et al.
Published: (2022-06-01)

Potential Therapeutic Role of Pituitary Adenylate Cyclase-Activating Polypeptide for Dry Eye Disease
by: Takahiro Hirabayashi, et al.
Published: (2022-01-01)

Increased pituitary adenylate cyclase-activating polypeptide in the central bed nucleus of the stria terminalis in mood disorders in men
by: Zala Slabe, et al.
Published: (2023-07-01)

Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Physiological and Pathological Processes within the Gastrointestinal Tract: A Review
by: Aleksandra Karpiesiuk, et al.
Published: (2021-08-01)

Spinal Astrocyte-Neuron Lactate Shuttle Contributes to the Pituitary Adenylate Cyclase-Activating Polypeptide/PAC1 Receptor-Induced Nociceptive Behaviors in Mice
by: Yuki Kambe, et al.
Published: (2022-12-01)

Correlation of Decreased Serum Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Levels With Non-motor Symptoms in Patients With Parkinson’s Disease
by: Shiyu Hu, et al.
Published: (2021-09-01)

The Neuropeptides Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Control HIV-1 Infection in Macrophages Through Activation of Protein Kinases A and C
by: Jairo R. Temerozo, et al.
Published: (2018-06-01)

Effects of Pituitary Adenylate Cyclase Activating Polypeptide on Cell Death
by: Gabriella Horvath, et al.
Published: (2022-04-01)

Seasonal changes in the expression of PACAP, VPAC1, VPAC2, PAC1 and testicular activity in the testis of the muskrat (<em>Ondatra zibethicus</em>)
by: Zeqi Tang, et al.
Published: (2022-05-01)

Impact Assessment of Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) and Hemostatic Sponge on Vascular Anastomosis Regeneration in Rats
by: Laszlo Adam Fazekas, et al.
Published: (2023-11-01)

Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) and Sudden Infant Death Syndrome: A Potential Model for Investigation
by: Dénes Tóth, et al.
Published: (2023-10-01)

Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors
by: Jessica Lu, et al.
Published: (2022-07-01)

Exploring the Pro-Phagocytic and Anti-Inflammatory Functions of PACAP and VIP in Microglia: Implications for Multiple Sclerosis
by: Margo I. Jansen, et al.
Published: (2022-04-01)

Diabetes Affects the Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)-Like Immunoreactive Enteric Neurons in the Porcine Digestive Tract
by: Katarzyna Palus, et al.
Published: (2021-05-01)

Bordetella Adenylate Cyclase-Hemolysin Toxins
by: Nicole Guiso
Published: (2017-09-01)

From CGRP to PACAP, VIP, and Beyond: Unraveling the Next Chapters in Migraine Treatment
by: Masaru Tanaka, et al.
Published: (2023-11-01)

Changes of Adenylate Cyclase and Guanylate Cyclase in the Frontal Cortex, Lenticula, Corpus Amygdaloideum, and Hippocampus in Morphine-dependent Rats
by: Shijun Hong, et al.
Published: (2016-01-01)

PACAP-38 Induces Transcriptomic Changes in Rat Trigeminal Ganglion Cells Related to Neuroinflammation and Altered Mitochondrial Function Presumably via PAC1/VPAC2 Receptor-Independent Mechanism
by: Krisztina Takács-Lovász, et al.
Published: (2022-02-01)

Pituitary Adenylate Cyclase-activating Polypeptide (PACAP) Treatment during Pre-maturation Increases the Maturation of Porcine Oocytes Derived from Small Follicles
by: Kyu-Mi Park, et al.
Published: (2018-03-01)

Signal Transduction by VIP and PACAP Receptors
by: Ingrid Langer, et al.
Published: (2022-02-01)

Localization of the neuropeptides pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal peptide, and their receptors in the basal brain blood vessels and trigeminal ganglion of the mouse CNS; an immunohistochemical study
by: Anne Marie Lund, et al.
Published: (2022-10-01)

Viral-Mediated Knockdown of Nucleus Accumbens Shell PAC1 Receptor Promotes Excessive Alcohol Drinking in Alcohol-Preferring Rats
by: Margaret A. Minnig, et al.
Published: (2021-12-01)

Editorial: Novel Therapeutic Potential for Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP), Vasoactive Intestinal Peptide (VIP) and Related Peptides in Cognition Deficits
by: Lucia Ciranna, et al.
Published: (2021-09-01)

Molecular dynamics simulation studies of novel marine psychrophilic adenylate kinase with mesophilic and thermophilic homologous /
by: Yusra Nazira Mohd. Yusop, 1991, author, et al.
Published: (2014)

Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine
by: Faisal Mohammad Amin, et al.
Published: (2018-05-01)

Molecular dynamics simulation studies of novel marine psychrophilic adenylate kinase with mesophilic and thermophilic homologous [electronic resource] /
by: Yusra Nazira Mohd. Yusop, 1991, author
Published: (2014)

Adenylate Cyclase Toxin Tinkering With Monocyte-Macrophage Differentiation
by: Jawid Nazir Ahmad, et al.
Published: (2020-09-01)